Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Antares Pharma: Update on Xyosted (ATRS, Buy, $2.34)

Regulatory Update

Antares announced that it has scheduled a Type A meeting with FDA for Xyosted which is intended to resolve…
Read more…